M K Proteins Ltd

BSE Code : 543919
NSE Symbol : MKPL
ISIN : INE964W01021
Industry :SOLVENT EXTRACTION

Trade Now

Get Quotes

7.25 0.14(1.97%)

Open Price (₹)

7.14

Prev. Close (₹)

7.11

Volume (No’s)

194,221

Market Cap (₹)

272.14

Low Price (₹)

7.14

High Price (₹)

7.28 Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Board Meetings

Start Date	End Date	Purpose
23-Aug-2025	23-Aug-2025	This is to inform that the Board of Directors of the Company at their Meeting held on 23rd August 2025 discussed and approved: 1. Appointment of Independent Director: Mr. Deepak Khetarpal (DIN: 00732804) was appointed as an Additional Director on the Board of the Company (Non-Executive, Independent Director) subject to the approval of members at the ensuing AGM of the Company. 2. Notice and Directors Report: The Board approved the notice of 13th AGM and the Directors Report along with annexures. 3. 13th AGM: The Board has decided that the 13th AGM of the members of M K Proteins Limited be held on Friday, 19th September 2025 at 11:30 AM through VC/OAVM. 4. Book Closure : the Register of Members and Share Transfer Books of the Company will remain close from Saturday, 13th September, 2025 to Friday 19th September 2025 (both days inclusive) for the purpose of holding AGM. Please note that the meeting of the Board of Directors commenced at 04:30 P.M. and concluded at 05:30 P.M.
04-Aug-2025	12-Aug-2025	M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday 12th August 2025 to inter-alia to consider and approve the following businesses: 1. The Un-Audited Financial Results of the Company for the quarter ended 30th June 2025; 2. Any other items with the permission of the Chairman. We hereby submit / inform that: 1. The Board has approved the Un-Audited Financial Results of the Company for the quarter ended 30th June, 2025. The said Un-Audited Financial Results together with the Limited Review Report (LRR) are enclosed. 2. M/s. KRA & Co., Statutory Auditors (FRN: 020266N), vide letter dated 5th August, 2025 have tendered their resignation as Statutory Auditors of the Company, effective from the closure of business hours of 12th August 2025. 3. On the recommendation of the Audit Committee, the Board has approved the appointment of M/s. Subhash Sajal & Associates, Chartered Accountants, (FRN: 018178N) as Statutory Auditors of the Company to fill the casual vacancy caused due to resignation of M/s. KRA & Co.. 4. Approved the appointment of M/s. J.P. Jagdev & Co., Peer Reviewed Firm of Practising Company Secretaries, (M. No: 2469, C.P. 2056) Secretarial Auditors of the Company (As Per BSE Announcement Dated on: 12/08/2025)
15-May-2025	23-May-2025	M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 inter alia to consider and approve 1. The Audited Financial Results of the Company for the quarter and year ended 31st March 2025; 2. Re-Appointment of M/s. K. K. Sinha & Associates Cost Accountants (Firm Regn. No. 100279) as the Cost Auditors of the Company for the financial year 2025-2026. 3. Any other items with the permission of the chairman. We hereby inform that the Board of Directors of the Company at its meeting held today i.e. on Friday, May 23, 2025, inter alia, considered and approved the following matters: 1. Audited Standalone Financial Results of the Company for the Quarter and Year ended on 31st March, 2025 together with a Statement of Cash Flow, Statement of Assets and Liabilities for the same period; 2. Auditors Report on the said Financial Results; 3. Declaration regarding unmodified opinion on Audited Standalone Financial Results under Regulation 33(3)(d) of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2016 (As Per BSE Announcement Dated on: 23/05/2025)
06-Feb-2025	13-Feb-2025	M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 inter alia to consider and approve the following items: 1. The Un-Audited Financial Results of the Company for the quarter and nine months ended 31st December 2024; 2. Any other business with the permission of chair. Pursuant to the Regulations 30 and 33 of SEBI (LODR) Regulations, 2015, we hereby inform that the Board of Directors of the Company at its meeting held today i.e. on Thursday, February 13, 2025, inter alia, considered and approved the Un-Audited Financial Results for the quarter and nine months ended December 31, 2024 along with the Limited Review Report thereon by the Statutory Auditors of the Company. A copy of the Un-Audited Financial Results along with Limited Review Report of the Auditors is attached herewith as Annexures. The meeting of the Board of Directors commenced at 05:00 P.M. and concluded at 05:40 P.M. (As Per BSE Announcement Dated on 13.02.2025)
05-Nov-2024	14-Nov-2024	M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve the following businesses: 1. The Un-audited Financial Results of the Company for the quarter and half year ended 30th September 2024; 2. Any other items with the permission of the chairman. Further pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for prevention of Insider Trading (Code) the Trading Window for trading in Equity shares of the Company will be accordingly re-open after 48 hours from the declaration of the aforesaid Financial Results. Pursuant to the Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the Company at its meeting held today i.e. on Thursday, November 14, 2024, inter alia, considered and approved the Un-Audited Financial Results for the quarter and half year ended September 30, 2024 along with the Limited Review Report thereon by the Statutory Auditors of the Company. A copy of the Un-Audited Financial Results along with Limited Review Report of the Auditors is attached herewith as Annexures. Please note that the meeting of the Board of Directors commenced at 04:00 p.m. and concluded at 4:30 p.m. You are requested to take the same on your record. (As Per BSE Announcement dated on 14.11.2024)